Ghrelin's unique role as the only circulating appetite-promoting hormone makes it a logical anti-obesity target — blocking ghrelin could reduce hunger, decrease fat storage, and shift energy balance toward weight loss.
The only hunger hormoneGhrelin uniquely promotes all three components of weight gain: increased eating, increased fat storage, and decreased fat burning — targeting it attacks obesity from multiple angles
What the researchers found
Ghrelin's unique status as the only circulating appetite-promoting hormone, combined with evidence from knockout and antibody studies, makes it a rational anti-obesity drug target for reducing hunger and fat accumulation.
Why it matters
Obesity is the largest public health crisis globally. Targeting the body's one hunger hormone is the most direct pharmacological approach to reducing appetite at its source.
How the study worked
Review of evidence supporting ghrelin antagonism for obesity treatment, covering knockout mice, immunoneutralization studies, ghrelin physiology, and therapeutic development challenges.
What this study cannot tell us
Review from 2003. Ghrelin antagonists have had limited clinical success partly due to appetite system redundancy. GLP-1 agonists have proven more clinically effective.
How to read the evidence
Moderate evidence from a review synthesizing knockout, antibody, and physiological data supporting ghrelin as an obesity target.
When this study was published
Published in 2003. Ghrelin antagonists have been less successful clinically than GLP-1 agonists, but the combination approach remains promising.
The bigger picture
While GLP-1 agonists have dominated obesity pharmacology by enhancing satiety, blocking the hunger signal (ghrelin) represents the complementary approach. Combining both could be the ultimate obesity treatment.
Questions still open
- Why have ghrelin antagonists been less successful than GLP-1 agonists?
- Could combining ghrelin blockade with GLP-1 agonism produce synergistic weight loss?
- Does the body compensate for ghrelin blockade through other hunger mechanisms?
Common questions
Can blocking ghrelin treat obesity?
Is this better than drugs like Ozempic?
Read the original research
Ghrelin as a potential anti-obesity target.
Current pharmaceutical design, 9(17), 1383-95
Citation
Horvath, Tamas L; Castañeda, Tamara; Tang-Christensen, Mads; Pagotto, Uberto; Tschöp, Matthias H. (2003). Ghrelin as a potential anti-obesity target.. Current pharmaceutical design, 9(17), 1383-95.